| Literature DB >> 31426567 |
Hana Michnová1,2, Šárka Pospíšilová1,2, Tomáš Goněc3, Iva Kapustíková4, Peter Kollár5, Violetta Kozik6, Robert Musioł6, Izabela Jendrzejewska6, Ján Vančo1, Zdeněk Trávníček1, Alois Čížek2, Andrzej Bąk7, Josef Jampílek8,9.
Abstract
A series of twenty-six methoxylated and methylated N-aryl-1-hydroxynaphthalene- 2-carboxanilides was prepared and characterized as potential anti-invasive agents. The molecular structure of N-(2,5-dimethylphenyl)-1-hydroxynaphthalene-2-carboxamide as a model compound was determined by single-crystal X-ray diffraction. All the analysed compounds were tested against the reference strain Staphylococcus aureus and three clinical isolates of methicillin-resistant S. aureus as well as against Mycobacterium tuberculosis and M. kansasii. In addition, the inhibitory profile of photosynthetic electron transport in spinach (Spinacia oleracea L.) chloroplasts was specified. In vitro cytotoxicity of the most effective compounds was tested on the human monocytic leukaemia THP-1 cell line. The activities of N-(3,5-dimethylphenyl)-, N-(3-fluoro-5-methoxy-phenyl)- and N-(3,5-dimethoxyphenyl)-1-hydroxynaphthalene-2-carbox- amide were comparable with or even better than the commonly used standards ampicillin and isoniazid. All promising compounds did not show any cytotoxic effect at the concentration >30 µM. Moreover, an in silico evaluation of clogP features was performed for the entire set of the carboxamides using a range of software lipophilicity predictors, and cross-comparison with the experimentally determined lipophilicity (log k), in consensus lipophilicity estimation, was conducted as well. Principal component analysis was employed to illustrate noticeable variations with respect to the molecular lipophilicity (theoretical/experimental) and rule-of-five violations. Additionally, ligand-oriented studies for the assessment of the three-dimensional quantitative structure-activity relationship profile were carried out with the comparative molecular surface analysis to determine electron and/or steric factors that potentially contribute to the biological activities of the investigated compounds.Entities:
Keywords: 3D-QSAR; CoMSA; MTT assay; PET inhibition; X-Ray structure; antimycobacterial activity; antistaphylococcal activity; cytotoxicity; hydroxynaphthalenecarboxamides; lipophilicity
Mesh:
Substances:
Year: 2019 PMID: 31426567 PMCID: PMC6720605 DOI: 10.3390/molecules24162991
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1Synthesis of ring-substituted 1-hydroxynaphthalene-2-carboxanilides 1–26. Reagents and conditions: (a) PCl3, chlorobenzene, MW, 15 min, [1,10].
Compositions of N-substituted 1-hydroxynaphthalene-2-carboxanilides, experimental log k values, in vitro antistaphylococcal activities MIC [μM] compared to ampicillin (AMP), in vitro antimycobacterial activities MIC [μM] compared to isoniazid (INH), in vitro cytotoxicity (Tox) assay (LD50 [μM]) of chosen compounds and IC50 [μM] values related to PET inhibition in spinach chloroplasts compared to 3-(3,4-dichlorophenyl)-1,1-dimethylurea (DCMU) standard.
| Comp. | R | log | MIC [μM] | Tox LD50 [μM] | PET IC50 [μM] | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| SA | MRSA 63718 | MRSA SA 630 | MRSA SA 3202 | MT | MK | |||||
|
| H a | 0.6769 | >972 | >972 | 243 | 122 | 486 |
| >30 | 31.3 |
|
| 2-OCH3 a | 0.8584 | >873 | >873 | >873 | >873 | 436 | >873 | – | 199 |
|
| 3-OCH3 a | 0.6713 | 109 | >873 | >873 | >873 | 436 | >873 | – | 23.5 |
|
| 4-OCH3 a | 0.6284 | 873 | >873 | >873 | >873 | 436 | >873 | – | 79.5 |
|
| 2,5-OCH3 b | 0.8712 | 791 | 395 | 395 | 197 | 396 | 24.7 | – | 201 |
|
| 3,5-OCH3 b | 0.7048 |
|
|
|
|
|
| >30 |
|
|
| 3,4,5-OCH3 b | 0.5603 | 724 | 724 | 724 | 724 | 22.6 | 90.5 | – | 468 |
|
| 2-CH3 a | 0.5650 | 115 | 231 | 231 | 231 | 462 | 115 | – | 62.8 |
|
| 3-CH3 a | 0.8235 | 115 | 923 | 923 | 462 | 462 | 28.8 | – | 20.0 |
|
| 4-CH3 a | 0.8294 | 923 | 923 | 923 | 923 | 462 | 57.7 | – | 28.7 |
|
| 2,5-CH3 b | 0.7155 |
|
|
|
| 110 | 220 | >30 | 52.4 |
|
| 2,6-CH3 b | 0.5990 | 55.0 | 110 | 110 | 110 | 110 | 220 | – | 60.3 |
|
| 3,5-CH3 b | 1.0030 |
|
|
|
|
|
| >30 |
|
|
| 2,4,6-CH3 b | 0.7477 | >838 | >838 | >838 | >838 | 13.1 | 104 | – | 295 |
|
| 2-OCH3-5-CH3 b | 1.0603 | >832 | >832 | >832 | >832 | 13.0 | 52.0 | – | 588 |
|
| 2-OCH3-6-CH3 b | 0.4574 | >832 | >832 | >832 | >832 | 52.0 | 104 | – | 747 |
|
| 2-CH3-5-OCH3 b | 0.5362 | 52.0 | 832 | 104 | 208 | 13.0 | 104 | – | 142 |
|
| 2-OCH3-4-NO2 b | 0.5434 | 756 | 756 | 756 | 756 | 378 | 756 | – | 495 |
|
| 2-OCH3-5-NO2 b | 0.4827 | 756 | 756 | 756 | 756 | 378 | 756 | – | 155 |
|
| 2-OCH3-5-Br | 1.0432 | 687 | 687 | 687 | 687 | 344 | 687 | – | 569 |
|
| 2-OCH3-5-CF3 b | 0.9428 | 708 | 708 | 708 | 708 | 354 | 708 | – | 26.4 |
|
| 3-CF3-4-OCH3 b | 0.8915 | 354 | 354 | 354 | 5.53 | 354 | 88.5 | – | 18.5 |
|
| 3-F-5-OCH3 | 0.7629 |
|
|
|
|
|
| >30 |
|
|
| 2-Cl-5-OCH3 b | 0.8130 | 781 | 781 | 781 | 781 | 24.4 | 781 | – | 60.9 |
|
| 2-CH3-5-CF3 b | 0.7479 | 741 | 741 | 741 | 741 | 46.3 | 92.6 | – | 36.7 |
|
| 3-CF3-4-CH3 b | 1.1411 | 741 | 741 | 741 | 741 | 371 | 741 | – | 16.3 |
|
| – | – | 5.72 | 45.8 | 45.8 | 45.8 | – | – | – | – |
|
| – | – | – | – | – | – | 36.6 | 233 | – | – |
|
| – | – | – | – | – | – | – | – | – | 2.1 |
a described in [1], b described in [10], SA = Staphylococcus aureus ATCC 29213; MRSA = clinical isolates of methicillin-resistant S. aureus 63718, SA 630, and SA 3202 (National Institute of Public Health, Prague, Czech Republic); MT = Mycobacterium tuberculosis H37Ra ATCC 25177, MK = M. kansasii DSM 44162.
Figure 1Molecular structure of N-(2,5-dimethylphenyl)-1-hydroxynaphthalene-2-carboxamide (11). Non-H atoms are drawn as thermal ellipsoids at 50% probability level. H-atoms are not labelled and are displayed as balls in light-grey colour.
Crystal data and structure refinement for 11.
| Formula | C19H17NO2 |
|---|---|
| Formula weight | 291.33 |
| Temperature | 120(2) K |
| Wavelength | 0.71073 Å |
| Crystal system | Monoclinic |
| Space group | |
| Unit cell dimensions | |
| Volume | 1491.3(15) Å3 |
|
| 4 |
| Density (calculated) | 1.298 g/cm3 |
| Absorption coefficient | 0.084 mm−1 |
| F(000) | 616 |
| Crystal size | 0.240 × 0.200 × 0.180 mm |
| Theta range for data collection | 1.974 to 25.074° |
| Index ranges | −8 ≤ h ≤ 8, −19 ≤ k ≤ 19, −16 ≤ l ≤16 |
| Reflections collected | 14255 |
| Independent reflections | 2635 [R(int) = 0.1005] |
| Completeness to θ | 25.074° (99.7%) |
| Absorption correction | Semi-empirical from equivalents |
| Refinement method | Full-matrix least-squares on |
| Data/restraints/parameters | 2635/0/201 |
| Goodness-of-fit on | 1.065 |
| Final | |
| Largest diff. peak and hole | 0.196 and −0.228 e.Å−3 |
Theoretically estimated partition coefficient calculated by set of alternative methods for N-(methoxy/methyl-phenyl)-1-hydroxynaphthalene-2-carboxamides 1–26.
| No. | logP a | miLogP b | ClogP c | ClogP d | ClogP e | ClogP f | ClogP g | MlogP h | AlogP i | ClogP j | ClogP k |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
| 3.98 | 4.27 | 3.65 | 3.51 | 4.43 | 3.75 | 4.50 | 3.91 | 3.26 | 4.47 | 4.20 |
|
| 4.27 | 4.28 | 3.58 | 3.25 | 3.93 | 3.59 | 4.40 | 3.61 | 3.24 | 3.99 | 4.17 |
|
| 4.25 | 4.30 | 3.58 | 3.25 | 4.52 | 3.59 | 4.66 | 3.61 | 3.24 | 4.55 | 4.17 |
|
| 4.23 | 4.33 | 3.58 | 3.25 | 4.52 | 3.59 | 4.45 | 3.61 | 3.24 | 4.55 | 4.17 |
|
| 3.95 | 4.31 | 3.51 | 3.00 | 3.96 | 3.44 | 4.61 | 3.06 | 3.22 | 4.07 | 4.15 |
|
| 4.02 | 4.31 | 3.51 | 3.00 | 4.55 | 3.44 | 4.70 | 3.06 | 3.22 | 4.63 | 4.15 |
|
| 3.47 | 3.90 | 3.44 | 2.75 | 3.81 | 3.28 | 4.46 | 2.51 | 3.21 | 3.98 | 4.12 |
|
| 4.44 | 4.67 | 3.99 | 3.97 | 4.29 | 4.26 | 4.96 | 4.15 | 3.74 | 4.46 | 4.57 |
|
| 4.47 | 4.69 | 3.99 | 3.97 | 4.94 | 4.26 | 4.96 | 4.15 | 3.74 | 5.02 | 4.57 |
|
| 4.47 | 4.72 | 3.99 | 3.97 | 4.94 | 4.26 | 4.96 | 4.15 | 3.74 | 5.02 | 4.57 |
|
| 4.72 | 5.09 | 4.34 | 4.44 | 4.79 | 4.78 | 5.42 | 4.38 | 4.23 | 5.00 | 4.93 |
|
| 4.69 | 4.13 | 4.34 | 4.44 | 4.14 | 4.78 | 5.42 | 4.38 | 4.23 | 4.44 | 4.93 |
|
| 4.74 | 5.09 | 4.34 | 4.44 | 5.44 | 4.78 | 5.42 | 4.38 | 4.23 | 5.57 | 4.93 |
|
| 4.54 | 4.53 | 4.68 | 4.91 | 4.64 | 5.29 | 5.88 | 4.61 | 4.71 | 4.99 | 5.30 |
|
| 4.57 | 4.70 | 3.93 | 3.72 | 4.43 | 4.11 | 4.86 | 3.84 | 3.73 | 4.54 | 4.54 |
|
| 4.50 | 4.68 | 3.93 | 3.72 | 3.78 | 4.11 | 4.86 | 3.84 | 3.73 | 3.98 | 4.54 |
|
| 4.59 | 4.70 | 3.93 | 3.72 | 4.37 | 4.11 | 5.12 | 3.84 | 3.73 | 4.54 | 4.54 |
|
| 4.10 | 4.21 | 2.66 | 1.27 | 4.21 | 3.53 | 4.79 | 3.39 | 3.13 | 4.53 | 4.00 |
|
| 4.07 | 4.21 | 2.66 | 1.27 | 4.21 | 3.53 | 4.95 | 3.39 | 3.13 | 4.53 | 4.00 |
|
| 4.07 | 5.06 | 4.31 | 4.04 | 4.99 | 4.36 | 5.86 | 3.95 | 3.99 | 4.88 | 4.87 |
|
| 4.82 | 5.15 | 4.43 | 4.14 | 5.23 | 4.47 | 6.44 | 4.18 | 4.18 | 4.95 | 5.06 |
|
| 4.82 | 5.15 | 4.43 | 4.14 | 5.82 | 4.47 | 6.26 | 4.18 | 4.18 | 5.52 | 5.06 |
|
| 4.65 | 4.42 | 3.69 | 3.39 | 4.86 | 3.74 | 5.20 | 3.73 | 3.44 | 4.75 | 4.27 |
|
| 5.14 | 4.93 | 4.19 | 3.77 | 4.58 | 4.20 | 5.26 | 3.84 | 3.90 | 4.63 | 6.08 |
|
| 5.12 | 5.54 | 4.85 | 4.86 | 5.63 | 5.14 | 6.31 | 4.99 | 4.68 | 5.42 | 5.45 |
|
| 5.07 | 5.54 | 4.85 | 4.86 | 6.28 | 5.14 | 6.31 | 4.99 | 4.68 | 5.98 | 5.45 |
a clogPS, b Molinspirations, c OSIRIS property explorer, d HyperChem 7.0, e Sybyl X, f Marvin Sketch (ChemAxon) 15, g ChemSketch 2015, h Dragon 6.0, i Dragon 6.0, j Kowwin, k XlogP3).
Figure 2Matrix of correlation coefficients of linear relationships between experimental lipophilicity (logk1) and calculated lipophilicity for series 1–26.
Figure 3Projection of derivatives 1–26 on plane defined by first vs. second principal component with: log k (a), number of Ro5 rule violations (b) and calculated in Sybyl-X lipophilicity (c). Colours code values of experimental lipophilicity, Ro5 violations and theoretical lipophilicity.
Figure 4Dependence of antimycobacterial activity of tested compounds against M. tuberculosis expressed as log(1/MIC [M]) on lipophilicity expressed as log k after elimination of non-active compounds.
Figure 5Spatial sectors with greatest contribution into activity specified as CoMSA IVE-PLS for selected 18/8 training/test set samplings. Colours indicate their effect (a) and four possible combination of mean charge q and correlation coefficient b values (b). Reference compound 23 is plotted as the most active one.